D.E. Shaw & Co
PRTK

D.E. Shaw & Co’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-396,076
Closed -$875K 3360
2023
Q2
$875K Buy
396,076
+42,577
+12% +$94.1K ﹤0.01% 2138
2023
Q1
$898K Sell
353,499
-39,197
-10% -$99.6K ﹤0.01% 2266
2022
Q4
$734K Buy
392,696
+83,132
+27% +$155K ﹤0.01% 2565
2022
Q3
$795K Buy
309,564
+191,355
+162% +$491K ﹤0.01% 2659
2022
Q2
$228K Buy
118,209
+41,278
+54% +$79.6K ﹤0.01% 3346
2022
Q1
$228K Buy
76,931
+48,518
+171% +$144K ﹤0.01% 3561
2021
Q4
$128K Sell
28,413
-27,094
-49% -$122K ﹤0.01% 3605
2021
Q3
$270K Sell
55,507
-51,401
-48% -$250K ﹤0.01% 3117
2021
Q2
$729K Sell
106,908
-109,745
-51% -$748K ﹤0.01% 2697
2021
Q1
$1.53M Sell
216,653
-179,008
-45% -$1.26M ﹤0.01% 1971
2020
Q4
$2.48M Sell
395,661
-218,893
-36% -$1.37M ﹤0.01% 1645
2020
Q3
$3.33M Sell
614,554
-403,911
-40% -$2.19M ﹤0.01% 1384
2020
Q2
$5.32M Buy
1,018,465
+457,341
+82% +$2.39M 0.01% 1151
2020
Q1
$1.77M Buy
561,124
+301,041
+116% +$948K ﹤0.01% 1574
2019
Q4
$1.05M Buy
260,083
+242,063
+1,343% +$975K ﹤0.01% 1896
2019
Q3
$78K Buy
+18,020
New +$78K ﹤0.01% 2465
2018
Q1
Sell
-20,071
Closed -$359K 2700
2017
Q4
$359K Buy
+20,071
New +$359K ﹤0.01% 2216
2017
Q1
Sell
-10,806
Closed -$166K 2655
2016
Q4
$166K Sell
10,806
-10,650
-50% -$164K ﹤0.01% 2360
2016
Q3
$279K Buy
+21,456
New +$279K ﹤0.01% 2228
2015
Q1
Sell
-98,315
Closed -$3.79M 2718
2014
Q4
$3.79M Buy
98,315
+82,915
+538% +$3.2M ﹤0.01% 1052
2014
Q3
$31K Sell
15,400
-44,313
-74% -$89.2K ﹤0.01% 2319
2014
Q2
$119K Buy
59,713
+7,550
+14% +$15K ﹤0.01% 2257
2014
Q1
$161K Buy
52,163
+601
+1% +$1.86K ﹤0.01% 2202
2013
Q4
$173K Buy
51,562
+14,914
+41% +$50K ﹤0.01% 2330
2013
Q3
$117K Buy
36,648
+7,363
+25% +$23.5K ﹤0.01% 2284
2013
Q2
$88K Buy
+29,285
New +$88K ﹤0.01% 2276